This company listing is no longer active
Oak Street Health Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Oak Street Health's earnings have been declining at an average annual rate of -42.7%, while the Healthcare industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 39.1% per year.
Información clave
-42.7%
Tasa de crecimiento de los beneficios
71.3%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 15.7% |
Tasa de crecimiento de los ingresos | 39.1% |
Rentabilidad financiera | n/a |
Margen neto | -23.6% |
Última actualización de beneficios | 31 Dec 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Oak Street Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 22 | 2,161 | -509 | 507 | 0 |
30 Sep 22 | 1,977 | -515 | 501 | 0 |
30 Jun 22 | 1,820 | -494 | 483 | 0 |
31 Mar 22 | 1,650 | -442 | 446 | 0 |
31 Dec 21 | 1,430 | -409 | 420 | 0 |
30 Sep 21 | 1,285 | -358 | 404 | 0 |
30 Jun 21 | 1,114 | -282 | 369 | 0 |
31 Mar 21 | 976 | -159 | 310 | 0 |
31 Dec 20 | 883 | -120 | 249 | 0 |
30 Sep 20 | 808 | -85 | 190 | 0 |
30 Jun 20 | 729 | -93 | 151 | 0 |
31 Mar 20 | 641 | -145 | 138 | 0 |
31 Dec 19 | 557 | -137 | 122 | 0 |
30 Sep 19 | 470 | -119 | 123 | 0 |
31 Dec 18 | 318 | -119 | 76 | 0 |
31 Dec 17 | 185 | -55 | 33 | 0 |
Ingresos de calidad: HE6 is currently unprofitable.
Margen de beneficios creciente: HE6 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: HE6 is unprofitable, and losses have increased over the past 5 years at a rate of 42.7% per year.
Acelerando crecimiento: Unable to compare HE6's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: HE6 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-26.5%).
Rentabilidad financiera
Alta ROE: HE6's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.